UTIAMC UTI AMC Q4 FY25 results (Jan–Mar 2025) and concall
UTI AMC delivered strong core operational growth in FY25, characterized by a 43% surge in consolidated core PAT and robust AUM expansion across mutual funds and pension segments. While overall net profit was slightly dragged down by mark-to-market (M-to-M) impacts in the international business, the company successfully turned around its equity performance and aggressively expanded its physical footprint. Management is focused on leveraging improved fund rankings to regain market share while maintaining cost discipline.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q3 FY25 | Q4 FY25 |
|---|---|---|
| Revenue | 329 | 317 |
| EBITDA | 200 | 181 |
| Net profit | 142 | 124 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
